RB1 and retinoblastoma: The ability of E7 to target PTPN14 for degradation maps to the N and C termini of E7 and is independent of RB1 binding by E7, making it consistent with previous suggestions in the literature that there is a retinoblastoma-independent transformation activity of E7.